Skip to Content
  • Previous Rank22
  • Revenues ($M)91,084
  • Revenue Percent Change-9.9%
  • Profits ($M)1,166
  • Profits Percent Change249.1%
  • Market Value (as of March 31, 2015)29,801

Cardinal Health, a drug wholesaler that also makes gloves and surgical apparel, has been on a buying spree lately in a bid to shore up future earnings. In March, Cardinal shelled out $1.94 billion to acquire Johnson & Johnson’s Cordis heart-product business, which allows Cardinal to add stents and catheters to the products it offers its clients. The deal follows on the heels of Cardinal’s long-term strategic agreement with Henry Schein in November 2014 and a contract manufacturing agreement with Bayer Healthcare during the second fiscal quarter this year. The partnerships and purchases are a way for Cardinal to expand its portfolio of medical products that it sells to hospitals, physicians and ambulatory centers. It’s also further expanding into added services and support for customers that are moving from the traditional hospital model to larger integrated systems across various sites of care.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
George S. Barrett
Industry
Wholesalers: Health Care
Sector
Wholesalers
HQ Location
Dublin, OH
Websitehttp://www.cardinal.com
Years on List21

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)91,084-9.9%
Profits ($M)1,166249.1%
Total Stockholder Equity6,401-
Employees34,000-
Market Value (as of March 31, 2015)29,801-

Profit Ratios

Profit as % of Revenues1.3%
Profits as % of Assets4.5%
Profits as % of Stockholder Equity18.2%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)3.38
EPS % Change (from 2013)248.5%
EPS % Change (5 year annual rate)1.2%
EPS % Change (10 year annual rate)0.1%

Total Return

Total Return to Investors (2014)23.1%
Total Return to Investors (5 year, annualized)22.7%
Total Return to Investors (10 year, annualized)8.4%